Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism

Abstract
No abstract available
Funding Information
  • University of Torino, Department of Clinical and Biological Sciences (BARG-RILO-19-01, PIZS-RILO-19-01)
  • Department of Scienza e Tecnologia del Farmaco (DIAC-RILO-18-01, DIAC-RILO-19-01)